| [1] |
Ferlar J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J/CD]. Int J Cancer, 2015, 136(5):E359-386.
|
| [2] |
Nie Y, Wu K, Yu J, et al. A global burden of gastric cancer: the major impact of China[J]. Expert Rev Gastroenterol Hepatol, 2017, 11(7): 651-661.
|
| [3] |
Yin J, Song JN, Bai ZG, et al. Gastric cancer mortality trends in China (2006-2013) reveal increasing mortality in young subjects[J]. Anticancer Res, 2017, 37(8):4671-4679.
|
| [4] |
Strong VE, D'Amico TA, Kleinberg L, et al. Impact of the 7th Edition AJCC staging classification on the NCCN clinical prac-tice guidelines in oncology for gastric and esophageal cancers[J]. J Natl Compr Canc Netw, 2013, 11(1):60-66.
|
| [5] |
Shinohara T, Maeda Y, Hamada T, et al. Survival benefit of surgical treatment for liver metastases from gastric cancer[J]. J Gastrointest Surg, 2015, 19(6):1043-1051.
|
| [6] |
Haider MT, Taipaleenmäki H. Targeting the metastatic bone microenvironment by microRNAs[J]. Front Endocrinol, 2018(9): 202.
|
| [7] |
Anfossi S, Fu X, Nagvekar R, et al. MicroRNAs, regulatory messengers inside and outside cancer cells[J]. Adv Exp Med Biol, 2018(1056):87-108.
|
| [8] |
Liu Y, Uzair-Ur-Rehman, Guo Y, et al. miR-181b functions asan oncomiR in colorectal cancer by targeting PDCD4[J]. Protein Cell, 2016, 7(10):722-734.
|
| [9] |
Chen Y, Li R, Pan M, et al. MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor[J]. J Neurooncol, 2017, 133(3): 477-485.
|
| [10] |
Li D, Jian W, Wei C, et al. Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer[J]. Int J Clin Exp Pathol, 2014, 7(11):7672-7680.
|
| [11] |
Xia Y, Gao Y. MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2[J]. Biochem Biophys Res Commun, 2014, 447(3):446-451.
|
| [12] |
中国研究型医院学会消化道肿瘤专业委员会，中国医师协会外科医师分会上消化道外科医师委员会，中国抗癌协会胃癌专业委员会，等．胃癌肝转移诊断与综合治疗中国专家共识（2019版）[J]. 中国实用外科杂志，2019, 39(5):405-411.
|
| [13] |
Petrelli F, Coinu A, Cabiddu M, et al. Hepatic resection for gastric cancer liver metastases: a systematic review and meta-analysis[J].J Surg Oncol, 2015, 111(8):1021-1027.
|
| [14] |
中国研究型医院学会消化道肿瘤专业委员会，中国医师协会外科医师分会多学科综合治疗专业委员会．胃癌多学科综合治疗协作组诊疗模式专家共识[J]．中国实用外科杂志，2017, 37(1):37-38.
|
| [15] |
陈德兴，张洪伟．胃癌肝转移治疗现状[J]．中国实用外科杂志，2019, 39(4):382-384, 390.
|
| [16] |
Li Z, Fan B, Shan F, et al. Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis:a prospectively comparative study[J]. World J Surg Onc, 2015(13): 212.
|
| [17] |
Ishida M, Shimabukuro M, Yagi S, et al. MicroRNA-378 regulates adiponectin expression in adipose tissue: a new plausible mechanism[J]. PLoS One, 2014, 9(11):e111537.
|
| [18] |
Yuan HL, Wang T, Zhang KH. MicroRNAs as potential biomarkers for diagnosis, therapy and prognosis of gastric cancer[J]. Onco Targets Ther, 2018(11):3891-3900.
|
| [19] |
Wang X, Gocek E, Liu CG, et al. MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3[J]. Cell Cycle, 2009, 8(5):736-741.
|
| [20] |
Ouyang YB, Lu Y, Yue S, et al. miR-181 targets multiple Bcl-2 family members and nfluences apoptosis and mitochondrial function in astrocytes[J]. Mitochondrion, 2012, 12(2):213-219.
|
| [21] |
Wang B, Hsu SH, Majumder S, et al. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3[J]. Oncogene, 2010, 29(12):1787-1797.
|
| [22] |
Yang CC, Hung PS, Wang PW, et al. miR-181 as a putative biomarker for lymph-node metastasis of oral quamous cell carcinoma[J]. Oral Pathol Med, 2011, 40(5):397-404.
|
| [23] |
Zheng J, Wu C, Xu Z, et al. Hepatic stellate cell is activated by microRNA-181b via PTEN/Akt pathway[J]. Mol Cell Biochem, 2015, 398(1/2):1-9.
|